Risks, Issues and Adverse Events Sample Clauses

The "Risks, Issues and Adverse Events" clause defines the responsibilities and procedures for identifying, reporting, and managing any risks, problems, or negative incidents that may arise during the course of a project or contractual relationship. Typically, this clause requires parties to promptly notify each other of any significant risks or adverse events, maintain records, and implement mitigation or corrective actions as necessary. Its core function is to ensure transparency and proactive management of potential problems, thereby minimizing disruption and allocating responsibility for addressing unforeseen issues.
Risks, Issues and Adverse Events. The Provider must adhere to NHS Board policies and procedures that evidence effective management of risk, issues and adverse events: • The Provider is responsible for mitigating risks, managing issues identified within the nationally designated service. The Provider must comply with the principles of effective risk management. • Potential threats to and challenges within systems should be identified at strategic and operational levels. The risks and issues should be entered onto a risk register and control measures should be reviewed at regular intervals. • The risk and issue register for the service should be referenced in the annual report and any significant risks or issues highlighted. It is expected that the service will detail the mitigation actions in relation to the risks identified and this will be discussed as part of the annual performance review.
Risks, Issues and Adverse Events. The Provider must adhere to NHS Board policies and procedures that evidence effective management of risk, issues and adverse events: Risk and issue management‌ • The Provider is responsible for mitigating risks, managing issues identified within the nationally designated service. The Provider must comply with the principles of effective risk management. • Potential threats to and challenges within systems should be identified at strategic and operational levels. The risks and issues should be entered onto a risk register and control measures should be reviewed at regular intervals. • The risk and issue register for the service should be referenced in the annual report and any significant risks or issues highlighted. It is expected that the service will detail the mitigation actions in relation to the risks identified and this will be discussed as part of the annual performance review. • The Provider will comply with national guidelines for managing significant adverse events Learning from adverse events through reporting and review: A national framework for Scotland, (Healthcare Improvement Scotland 2019) to support effective management of adverse events and drive improvements in care across Scotland. • If a significant adverse event occurs, the Provider should inform NSD with immediate effect (for other adverse events these should be reported within three working days). Thereafter the Provider and NSD will agree the lead investigating organisation, roles and responsibilities of each party. • The Provider must comply with the principles of Duty of Candour, ensuring transparency with patients, carers and colleagues when an adverse event occurs which causes, or has the potential to cause, harm or distress.

Related to Risks, Issues and Adverse Events

  • Adverse Events Subsequent to the date hereof, there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange, the NASDAQ National Market or the NASDAQ Global Market, (ii) a general moratorium on commercial banking activities in the People’s Republic of China or New York, (iii) the outbreak or escalation of hostilities involving the United States or the People’s Republic of China or the declaration by the United States or the People’s Republic of China of a national emergency or war if the effect of any such event specified in this clause (iii) in your reasonable judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus, or (iv) such a material adverse change in general economic, political, financial or international conditions affecting financial markets in the United States or the People’s Republic of China having a material adverse impact on trading prices of securities in general, as, in your reasonable judgment, makes it impracticable or inadvisable to proceed with the public offering of the Shares or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus.

  • SIGNS AND ADVERTISING Tenant may, at its own expense, install and operate necessary and appropriate identification signs on the Premises, subject to the approval of Director and the requirements of the TI Guide, including but not limited to, the approval of the number, size, height, location, color and general type and design. Such approval shall be subject to revocation by Director at any time. Without express written consent of Director, Tenant shall not display any advertising, promotional, or informational pamphlets, circulars, brochures or similar materials.

  • Adverse Event Reporting Both Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

  • Notification and Advertising The invitation to prequalify or bid for each contract estimated to cost $10,000,000 equivalent or more shall be advertised in accordance with the procedures applicable to large contracts under paragraph 2.8 of the Guidelines. Part C: Other Procurement Procedures

  • SIGNS AND ADVERTISEMENTS No sign, advertisement, or notice referring to Tenant shall be inscribed, painted, affixed, or otherwise displayed on any part of the exterior or the interior of the Building, except those installed by Landlord on the directories and the entrance door to the Premises and such other areas, if any, as Landlord may determine. As long as Tenant leases all of the Rentable Area in the Building and occupies for normal business purposes at least fifty percent (50%) of the Rentable Area in the Building (with such other Rentable Area being occupied for normal business purposes by Tenant's permitted assignees or sublessees), then Tenant shall have the exclusive right, at its sole cost and expense, to (i) install a sign on the top level exterior of the Building and (ii) install a monument sign at the main drive or parking entrance to the Building bearing Tenant's then current corporate logo as it uses in its business (collectively, the "SIGNS"). The Signs shall conform to all applicable zoning and governmental ordinances and the Fair Lakes signage standards and shall be subject to the reasonable approval of Landlord and the Fair Lakes League as to location, size and design. Tenant shall be obligated, at its sole cost and expense, to install, maintain, repair and remove the Signs. If Tenant exhibits or installs any sign, advertisement or notice except the Signs, Landlord shall have the right to remove the same at Tenant's expense. Landlord shall have the right to prohibit any advertisement of or by Tenant which in its opinion tends to impair the reputation of the Building or its desirability as a high-quality office building and, upon written notice from Landlord, Tenant shall immediately refrain from and discontinue any such advertisement. Except as otherwise set forth above, Landlord reserves the right to affix, install, and display signs, advertisements, and notices on any part of the exterior or interior of the Building.